.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Kind Medicine concentrated 82.24% category share in Tincture & Sublingual, where sales moved 23.04% month over month but fell 11.44% year over year, while Capsules held 8.99% share with a 254.41% MoM spike against a 70.60% YoY decline. Topical represented 8.77% share with a 6.89% MoM contraction and a 57.21% YoY drop, and the brand’s average price rose 4.23% YoY to $35.48. With Tincture & Sublingual ranked 19th in California, the mix signals a defensive lean into the leading format alongside opportunistic but volatile Capsules recovery, implying the brand is consolidating around its core while probing secondary formats for incremental share despite a 30.53% brand-level YoY sales decline.
The July 2026 mix and rate shifts imply Kind Medicine’s positioning is anchored in Tincture & Sublingual scale (82.24% share, rank 19) while pursuing margin or basket-size trials via higher-priced Capsules (average price $56.06) that can swing volume quickly (254.41% MoM) yet remain fragile year over year (-70.60%). The concurrent 6.89% MoM decline and 57.21% YoY decline in Topical, versus a 23.04% MoM lift in Tincture & Sublingual, suggests resource reallocation toward the core where near-term velocity is improving, positioning the brand to stabilize share in California through depth in its primary format while treating Capsules as a tactical growth lever rather than a foundational pillar.
Competitive Landscape
Kind Medicine is ranked #19 in California Tincture & Sublingual in July 2026, slipping 1 position year over year from #18, but improving 10 spots from April 2026’s #29; the brand also sits 2 places below its historical peak of #17 from April 2025. Competitive movement is polarized: Yummi Karma climbed from #2 to #1 alongside a 16.2% year-over-year sales increase, while Papa & Barkley fell from #1 to #2 with a 13.6% decline; ABX / AbsoluteXtracts rose from #7 to #5 with 30.2% growth. The pattern—minor YoY rank erosion (down 1) paired with a recent quarter rebound (up 10 since April 2026)—implies Kind Medicine is stabilizing mid-pack but must capture share from faster risers to regain a top-15 footing.
Notable Products
Indica Capsules 32-Pack (960mg) posted the largest move in July 2026 with a 412.3% month-over-month surge into rank 6, while Menthol Rub (400mg THC, 60ml) slid 32.2% to rank 7. Sativa Tincture (1000mg THC, 30ml) climbed 128.9% and Sativa Tincture (800mg THC, 30ml) rose 104.7%, yet Indica Tincture (1000mg THC,30ml) fell 49.5% at rank 3, creating a bifurcation within the tincture set. With five of the top ten coming from Tincture & Sublingual and two Topicals both declining by 32.2% and 38.3%, the mix indicates a pivot toward higher-THC sativa formats and away from topical relief, concentrating demand in ingestible potency tiers rather than external-use SKUs.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
